HIV drug resistance: brief report 2024
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment. In this report, WHO documents
Drugs
-
Doctors told to administer Tamiflu to high-risk patients
Pune: With the number of swine flu cases increasing across Maharashtra, the state health machinery has turned to the old treatment protocol. State health minister Deepak Sawant announced on Thursday
-
Kenya's New HIV Treatment Offers Hope for Patients
NAIROBI - Kenya is set to be the first African country to introduce better HIV treatment for people living with the disease that causes AIDS. In partnership with the Kenyan government, UNITAID and the
-
Kenyans are first in Africa to get generic of latest AIDS drug
Kenya is the first African country to start using a generic version of the latest AIDS drug that can improve and prolong the lives of tens of thousands of people who suffer severe side effects and resistance
-
Nigeria prey to more deadly meningitis outbreaks amid vaccine shortage
DAKAR (Thomson Reuters Foundation) - Hit by one of its deadliest meningitis outbreaks in years, with more than 1,000 deaths, Nigeria could struggle to contain future epidemics due to a shortage of vaccines,
-
Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial
<p>Prolonged treatment of tuberculosis (TB) often leads to poor compliance, default and relapse, converting primary TB patients into category II TB (Cat IITB) cases, many of whom may convert to multi-drug
-
WHO revises antibiotics protocol
In an effort to curb antibiotic resistance, the World Health Organization (WHO) has divided the drugs into three categories — access, watch and reserve — specifying which are to be used for common ailments
-
Dissemination of antibiotic resistance genes from antibiotic producers to pathogens
<p>It has been hypothesized that some antibiotic resistance genes (ARGs) found in pathogenic bacteria derive from antibiotic-producing actinobacteria. Here we provide bioinformatic and experimental evidence
-
Genetic contribution of CYP1A1 variant on treatment outcome in epilepsy patients: a functional and interethnic perspective
<p>CYP1A1 gene is involved in estrogen metabolism, and previously, we have reported association of variant rs2606345 with altered anti-epileptic drugs (AED) response in North Indian women with epilepsy
-
WHO eyes vaccine trial for Ebola-hit DRC
Geneva - An unlicensed Ebola vaccine could soon be tested in a remote region of the Democratic Republic of Congo hit by an outbreak of the virus, the World Health Organisation said on Thursday. There
-
WHO may deploy Ebola vaccine for first test in DRC
To address the fresh outbreak of Ebola Virus Disease (EVD) in the Democratic Republic of Congo (DRC), the World Health Organisation (WHO) may deploy an experimental Ebola vaccine against the scourge for